Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC)
Completed · Phase 2 · Has a placebo group
Conditions studied: Primary Sclerosing Cholangitis (PSC)
In brief
The purpose of this study is to evaluate whether simtuzumab (GS-6624) is effective at preventing the progression of liver fibrosis in adults with primary sclerosing cholangitis (PSC).
Key facts
- Study ID
- NCT01672853
- Run by
- Gilead Sciences
- People needed
- 235
- Starts
- 2013-03-04
- Expected to finish
- 2016-08-24
- Last updated by the study team
- 2019-10-22
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Arizona Health Sciences Center — Tucson, Arizona, United States
- Southern California Liver Center — Chula Vista, California, United States
- Southern California Liver Centers — Coronado, California, United States
- Scripps Clinic — La Jolla, California, United States
- Verterans Adminstration Hospital — Palo Alto, California, United States
- UC Davis Medical Center — Sacramento, California, United States
- University of San Diego Medical Center — San Diego, California, United States
- University of California San Francisco — San Francisco, California, United States
- University of Colorado Denver — Aurora, Colorado, United States
- University of Miami Center for Liver Diseases — Miami, Florida, United States
- Northwestern University — Chicago, Illinois, United States
- Indiana University — Indianapolis, Indiana, United States
- Indianapolis Gastroenterology Research Foundation — Indianapolis, Indiana, United States
- Iowa Digestive Disease Center — Clive, Iowa, United States
- University of Louisville — Louisville, Kentucky, United States
- Tulane University Health Sciences Center — New Orleans, Louisiana, United States
- Walter Reed National Military Medical Center — Bethesda, Maryland, United States
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Minnesota Gastroenterology, PA — Saint Paul, Minnesota, United States
- St. Louis University — St Louis, Missouri, United States
- Weill Cornell Medical College — New York, New York, United States
- Mount Sinai Hospital — New York, New York, United States
- Duke Clinical Research Institute — Durham, North Carolina, United States
- Mayo Clinic Hospital — Phoenix, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.